World's Best Scientists 2026 revealed!
Mitchell F. Brin

Mitchell F. Brin

D-Index & Metrics

Medicine

D-Index
92
Citations
33428
World Ranking
11249
National Ranking
29

Mitchell F. Brin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mitchell F. Brin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 398 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mitchell F. Brin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mitchell F. Brin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mitchell F. Brin is affiliated with Allergan (Ireland) in Ireland and has an extensive publication record in the field of medicine, particularly focusing on neurological disorders and treatments.

Their research primarily centers on the application and mechanism of botulinum toxin, with a significant emphasis on neurological implications and related therapeutic uses. The main scientific fields covered include medicine, with specific focus areas in neurology, psychiatry and mental health, physiology, dermatology, and cardiology and cardiovascular medicine.

Key topics explored in their work include:

  • Botulinum Toxin and Related Neurological Disorders
  • Migraine and Headache Studies
  • Neurological disorders and treatments
  • Facial Rejuvenation and Surgery Techniques
  • Pain Mechanisms and Treatments
  • Sympathectomy and Hyperhidrosis Treatments
  • Cardiac Arrhythmias and Treatments

Notable recent publications authored or co-authored by Mitchell F. Brin include:

  • Botox (onabotulinumtoxinA) mechanism of action, 2023, Medicine
  • Guidance for the diagnosis and treatment of hypolipidemia disorders, 2022, Journal of clinical lipidology
  • Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review, 2020, Headache The Journal of Head and Face Pain
  • The effects of intensive speech treatment on intelligibility in Parkinson's disease: A randomised controlled trial, 2020, EClinicalMedicine
  • A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine, 2020, Headache The Journal of Head and Face Pain

Mitchell F. Brin frequently publishes in the following venues:

  • Medicine
  • Toxicon
  • Cephalalgia
  • Neurology
  • Toxins

Collaborations form an integral part of their research activity. The scientist has frequently co-authored with:

  • Aubrey Manack Adams
  • Rami Burstein
  • Elisabeth Lee
  • Ron S. Broide
  • Amy Brideau-Andersen

Mitchell F. Brin's body of work reflects a consistent focus on advancing understanding of botulinum toxin usage in neurology, with significant attention to migraine, headache disorders, and related therapeutic applications, while also addressing broader topics within medicine and neurological health.

Best Publications

  • Consensus statement of the Movement Disorder Society on tremor

    Günther Deuschl;Peter Bain;Mitchell Brin

  • A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease†

    C. Warren Olanow;Christopher G. Goetz;Jeffrey H. Kordower;A. Jon Stoessl

  • Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

    W. Koller;C. W. Olanow;R. Rodnitzky;J. S. Fink

  • The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein

    Laurie J. Ozelius;Jeffrey W. Hewett;Curtis E. Page;Susan B. Bressman

  • THERAPEUTIC USES OF BOTULINUM TOXIN

    Joseph Jankovic;Mitchell F. Brin

  • OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

    David W. Dodick;Catherine C. Turkel;Ronald E. Degryse;Sheena K. Aurora

  • Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.

    Brigitte Schurch;Marianne de Sèze;Pierre Denys;Emmanuel Chartier-Kastler

  • Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology

    Mitchell F. Brin

  • Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

    Francisco Cruz;Sender Herschorn;Philip Aliotta;Mitchell Brin;Mitchell Brin

  • Idiopathic cervical dystonia: Clinical characteristics

    Jane Chan;Mitchell F. Brin;Stanley Fahn

  • Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.

    Mitchell F. Brin;Stanley Fahn;Carol Moskowitz;Andrzej Friedman

  • Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12-year experience in more than 900 patients

    Andrew Blitzer;Mitchell F. Brin;Celia F. Stewart;Celia F. Stewart

  • Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

    William J. Binder;Mitchell F. Brin;Andrew Blitzer;Larry D. Schoenrock

  • The DYT1 phenotype and guidelines for diagnostic testing

    Susan B Bressman;C Sabatti;Deborah Raymond;D de Leon

  • Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

    A. Brashear;M. F. Lew;D. D. Dykstra;C. L. Comella

  • Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis.

    P. Greene;U. Kang;S. Fahn;M. Brin

  • Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity

    David Ginsberg;Angelo Gousse;Veronique Keppenne;Karl-Dietrich Sievert

  • Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).

    Andrew Blitzer;Mitchell F. Brin;Stanley Fahn;Robert E. Lovelace

  • Human gene for torsion dystonia located on chromosome 9q32-q34.

    Laurie Ozelius;Patricia L. Kramer;Carol B. Moskowitz;David J. Kwiatkowski

  • Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

    Lindsay A. Farrer;Mitchell F. Brin;Louis Elsas;Alison Goate

Frequent Co-Authors

Stanley Fahn
Stanley Fahn Columbia University
William C. Koller
William C. Koller University of Miami
Laurie J. Ozelius
Laurie J. Ozelius Harvard University
Xandra O. Breakefield
Xandra O. Breakefield Harvard University
Andres M. Lozano
Andres M. Lozano University of Toronto
John G. Nutt
John G. Nutt Oregon Health & Science University
Patricia L. Kramer
Patricia L. Kramer Oregon Health & Science University
Andrew J. Lees
Andrew J. Lees University College London
Susan B. Bressman
Susan B. Bressman Mount Sinai Beth Israel
Neil Risch
Neil Risch University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring diverse routes in healthcare, a range of online degrees and accelerated career options are available. Many aspiring nurses are seeking rn to bsn programs without clinicals, which allow experienced RNs to advance their qualifications without additional on-site requirements. This can be a flexible solution for working professionals.

Those aiming for doctoral credentials can also benefit from online options. If speed is a main priority, the shortest post master's dnp program pathways can help nurses reach the highest clinical level in less time. For those concerned about research and writing, dnp programs without dissertation have become increasingly popular, offering a more practical, project-based approach.

Entry-level students can also find fast-paced opportunities, such as an accelerated lpn program. These programs make it possible to jumpstart a nursing career quickly while studying online. Each of these career pathways is designed to fit different goals and lifestyles, opening doors to advancement in the medical field.

Best Scientists Citing Mitchell F. Brin

Trending Scientists

Recently Published Articles